Nutritional Ketosis in Heart Failure

Summary

Chronic, ambulatory heart failure patients will be given ketone ester dietary supplementation to determine therapeutic efficacy, metabolic adaptation, pharmacokinetics, associated cognitive changes, and safety within this patient cohort in order to establish preliminary data to later conduct a multi-center randomized clinical trial.

Timeline

Start

2020-06

Primary completion

2021-06

Completion

2021-06

Drugs

Indications